NV5 Share Price Performance
€0.042
-0.01 (-12.76%)
Price €0.042
Share Pricen/a
AcuCort AB (publ) Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
NV5 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
AcuCort AB (publ) Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
- -0.11
- -139.38%
- -312.21%
- 0%
About NV5
- Founded
- 2006
- Employees
- 4
- CEO
- WebsiteView website
AcuCort AB (publ) develops and commercializes glucocorticoid dexamethasone films for the treatment of acute allergic conditions. It offers Zeqmelit, a medicine used for the treatment of severe and acute allergic reactions, croup in children, and chemotherapy-induced nausea and vomiting, as well as for the treatment of COVID-19 patients who need supplemental oxygen treatment. AcuCort AB (publ) was incorporated in 2006 and is based in Lund, Sweden.
